A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.

Katz, B A; Elrod, K; Luong, C; Rice, M J; Mackman, R L; Sprengeler, P A; Spencer, J; Hataye, J; Janc, J; Link, J; Litvak, J; Rai, R; Rice, K; Sideris, S; Verner, E; Young, W

Katz, B A; Elrod, K; Luong, C; Rice, M J; Mackman, R L; Sprengeler, P A; Spencer, J; Hataye, J; Janc, J; Link, J; Litvak, J; Rai, R; Rice, K; Sideris, S; Verner, E; Young, W.

Affiliation

Katz BA; Axys Pharmaceuticals Corporation, 385 Oyster Point Boulevard, Suite 3, South San Francisco, CA, 94080, USA. brad_katz@axyspharm.com

J Mol Biol ; 307(5): 1451-86, 2001 Apr 13.

Article de En | MEDLINE | ID: mdl-11292354

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Serine endopeptidases / Inhibiteurs de la sérine protéinase Type d'étude: Prognostic_studies Langue: En Journal: J Mol Biol Année: 2001 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Pays-Bas

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links